In women with primary breast cancer diagnosis recruited to the Health, Eating, Activity, and Lifestyle (HEAL) Study, circulating levels of inflammatory biomarkers serum amyloid A (SAA) and C-reactive protein were associated with reduced disease-free survival (comparison of highest to lowest tertiles, SAA: HR = 2.91 (95% CI, 1.61–5.26); CRP: HR = 2.05 (95% CI, 1.14–3.69)) [79]. Here, CRP is linked to breast cancer.